Every acquisition starts with the numbers. Revenue trends, EBITDA adjustments, working capital cycles. Financial due diligence excels at answering whether those numbers are real. But here is the question most deal teams fail to ask early enough: are those numbers sustainable?
That gap between "verified" and "viable" is where investments break down. Commercial due diligence fills it by evaluating the market, customer, and competitive forces that financial models alone cannot capture. PE firms and strategy teams can close those gaps with independent, decision-first primary research.
This post compares the two disciplines side by side, identifies the specific blind spots each one misses, and explains how independent commercial risk assessment changes the investment thesis.
Financial due diligence is the forensic review of a target's historical accounting records. Its core output is a quality of earnings analysis that adjusts reported EBITDA for one-time items, non-recurring revenue, and accounting policy choices.
This discipline answers precise, quantifiable questions. Is the reported revenue real? Are the margins sustainable at current operating levels? What are the normalized working capital requirements?
Those answers matter. No serious transaction should proceed without them. A rigorous financial review identifies accounting irregularities, quantifies off-balance-sheet obligations, and stress-tests management projections against historical patterns.
Financial due diligence tells you what happened. It cannot tell you what will happen next. The most thorough quality of earnings report in the world cannot detect that a target's largest customer is evaluating an alternative provider.
It cannot identify a downward shift in category sentiment, a declining Net Promoter Score, or a new competitor gaining traction in the target's core segment. Financial models project future growth from historical trends, but those trends may already be breaking.
This is the structural blind spot. Financial diligence validates the rearview mirror. It reveals nothing about the road ahead.
Commercial due diligence assesses the external environment around the target: market size and trajectory, competitive positioning, customer health, regulatory landscape, and the sustainability of the target's differentiation.
Where financial diligence is forensic and backward-looking, commercial diligence is strategic and forward-looking. It evaluates total addressable market, customer retention and churn risk, barriers to entry, and realistic growth drivers.
The concept of commercial due diligence is sound. The execution, in many cases, falls short of its promise. Most engagements follow a predictable pattern: desk research from published market reports, a handful of expert network calls, and a management-curated reference list of satisfied customers.
That process generates a report built almost entirely on secondary data and curated narratives. The people who generate 100% of the target's revenue, the actual customers, are represented by three to five hand-selected references that management chose to make the most favorable impression possible.
This is not a minor oversight. It is a structural flaw that undermines the entire commercial assessment.
Financial models are built on historical data. That data cannot account for the following non-financial risks:
A revenue concentration analysis can flag that three customers represent 40% of sales. What it cannot reveal is that two of those customers are actively evaluating competitors. Only independent primary research with those customers will surface that risk before closing.
Financial statements reflect market share as it was, not as it is becoming. A new entrant gaining traction or a substitute product category growing in relevance will not appear in last quarter's revenue data. It will, however, appear in what customers tell an independent researcher when asked directly.
Projected revenue growth often assumes annual price increases. Customer interviews test whether those increases will hold or trigger churn. The distance between a model that assumes 5% annual pricing power and a customer base already sensitive at current levels is the gap between a sound investment and a value trap.
Supply chain dependencies, talent concentration, and key-person risk do not surface in financial statements until they become crises. A competitive intelligence assessment can detect these vulnerabilities before they become write-downs.
Category sentiment can shift quietly. Customers may still be buying today, but their perception of the brand's relevance, quality, or value is declining. By the time that sentiment shows up in churn data, the damage is already done. Qlarity Access identifies these signals early by going directly to the people who matter: actual buyers and users in the target's market.
Even when a deal team invests in a commercial assessment, the quality of the conclusions depends on the quality of the primary evidence. Without independent customer interviews, commercial diligence is exposed to its own set of vulnerabilities:
Management-selected references are structurally biased. No rational team hands over contacts who are frustrated, considering alternatives, or reducing spend. In practice, reference call satisfaction scores run significantly higher than independently recruited interviews for the same company.
Expert network calls offer informed perspective, but they are not primary evidence from the target's actual customer base. Industry consultants can describe macro trends. They cannot tell you what a target's mid-market customers think about the product's brand positioning relative to a newer entrant.
Market reports capture conditions as of their publication date. In fast-moving categories, the gap between secondary reports and the current reality can be material. Real-time intelligence from current customers closes that gap.
|
|
|
|
|---|---|---|
|
Core question |
Are the numbers accurate? |
Are the numbers sustainable? |
|
Time orientation |
Backward-looking |
Forward-looking |
|
Customer insight |
✗ |
✓ |
|
Competitive threat detection |
✗ |
✓ |
|
Market growth validation |
✗ |
✓ |
|
Pricing power assessment |
✗ |
✓ |
Customer interviews are not a separate workstream. They are the primary research methodology that gives commercial due diligence its empirical foundation. Every critical dimension of a commercial assessment depends on what customers think, intend, and do.
Independent research recruited without target management involvement reveals what curated references hide: switching risk, competitive threats that management may minimize, unmet needs that limit expansion potential, and pricing sensitivity that financial projections overlook.
Qlarity Access conducts this research using strict double-blind methodologies through the Qlarity Confidence Cycle. Neither the target company's customers nor broader market participants know who is conducting the research or which asset is being evaluated. This protects strategic intent while generating the unfiltered evidence base your investment committee needs.
Through the Emotional Drivers Framework, Qlarity Access goes beyond surface-level satisfaction metrics. The framework maps the rational and emotional motivations behind purchase decisions, loyalty, and brand perception, isolating the target brand's true commercial strengths and vulnerabilities.
Our approach also quantifies realistic market sizing by investigating non-customer perceptions and actual willingness to buy, giving your deal team a credible view of the addressable opportunity that goes beyond management-supplied estimates.
The most effective deal teams treat financial and commercial due diligence as interconnected disciplines, not independent checkboxes. Findings from each stream should cross-pollinate the other.
If financial diligence flags high revenue concentration, commercial diligence must assess the loyalty and intent of those key accounts. If commercial diligence identifies a growing competitor, financial projections must stress-test revenue retention under that competitive pressure. A McKinsey analysis on outside-in diligence reinforces that the best deal teams combine internal financial forensics with external market intelligence for a complete picture.
Broad research providers deliver data. Qlarity Access delivers clarity. The distinction matters when the stakes are measured in deployed capital and portfolio outcomes.
With nearly three decades of market research infrastructure and experience, Qlarity Access brings a combination of capabilities purpose-built for the high-pressure timeline of deal diligence: strict double-blind methodologies to protect strategic intent, a built-in network of more than 400,000 agriculture professionals and 28,000 animal health professionals, and the research design rigor that turns raw intelligence into decision-ready evidence.
Your investment committee does not need another 100-page report built on desk research and curated references. It needs independent, primary evidence from the people who generate the target's revenue. Qlarity Access delivers exactly that.
Ready to pressure-test your next investment thesis with independent market evidence? Contact Qlarity Access to set up a discussion with one of our Insights Directors.
Financial due diligence (FDD) is forensic and backward-looking—auditing historical accounting records and Quality of Earnings (QoE) to confirm past performance. Commercial due diligence (CDD) is strategic and forward-looking—evaluating market growth, customer intent, and competitive dynamics to verify whether those earnings are sustainable.
QoE reports extrapolate future growth from past financial data, leaving them blind to non-financial risks before they hit the P&L. They cannot detect early customer switching intent, emerging competitor traction, pricing resistance, or quiet shifts in overall market sentiment.
Management-curated reference lists are inherently biased toward top-tier accounts with high satisfaction and stable spend. Relying solely on curated references masks broader portfolio dissatisfaction, hidden churn risk, and competitive threats that unprompted, double-blind primary research exposes.
Primary research adds value across three deal stages: Pre-LOI (a 1-to-2 week sprint to test high-risk thesis assumptions), Post-LOI (full-scope customer, competitive, and pricing analysis for the Investment Committee), and Post-Close (setting a customer health baseline for the 100-day plan).